The Chemours Company (CC)
NYSE: CC · Real-Time Price · USD
13.85
-0.15 (-1.07%)
At close: Oct 28, 2025, 4:00 PM EDT
13.83
-0.02 (-0.14%)
After-hours: Oct 28, 2025, 7:40 PM EDT
The Chemours Company Stock Forecast
Stock Price Forecast
The 8 analysts that cover The Chemours Company stock have a consensus rating of "Buy" and an average price target of $18, which forecasts a 29.96% increase in the stock price over the next year. The lowest target is $13 and the highest is $27.
Price Target: $18 (+29.96%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for The Chemours Company stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 4 | 4 | 4 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Mizuho | Mizuho | Buy Maintains $19 → $18 | Buy | Maintains | $19 → $18 | +29.96% | Oct 16, 2025 |
| UBS | UBS | Strong Buy Maintains $17 → $21 | Strong Buy | Maintains | $17 → $21 | +51.62% | Oct 6, 2025 |
| Mizuho | Mizuho | Buy Maintains $16 → $19 | Buy | Maintains | $16 → $19 | +37.18% | Sep 23, 2025 |
| Truist Securities | Truist Securities | Strong Buy Maintains $18 → $21 | Strong Buy | Maintains | $18 → $21 | +51.62% | Sep 16, 2025 |
| Mizuho | Mizuho | Buy Maintains $13 → $16 | Buy | Maintains | $13 → $16 | +15.52% | Jul 15, 2025 |
Financial Forecast
Revenue This Year
6.06B
from 5.78B
Increased by 4.88%
Revenue Next Year
6.08B
from 6.06B
Increased by 0.21%
EPS This Year
1.23
from 0.57
Increased by 116.32%
EPS Next Year
2.18
from 1.23
Increased by 77.00%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 6.2B | 6.5B | |
| Avg | 6.1B | 6.1B | |
| Low | 5.7B | 3.9B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 7.7% | 7.6% | |
| Avg | 4.9% | 0.2% | |
| Low | -1.6% | -36.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 1.58 | 2.84 | |
| Avg | 1.23 | 2.18 | |
| Low | 1.03 | 1.43 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 176.3% | 129.9% | |
| Avg | 116.3% | 77.0% | |
| Low | 80.5% | 16.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.